SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...
The Ferrero Group continues its growth trajectory with an 8.9% increase in turnover to EUR18.4 billion. Continued innovation across new products and categories including the launch of Nutella Ice Cream in the same year...
GUANGZHOU, China, Feb. 13, 2025 /PRNewswire/ -- As China's No.1 platform for international trade, the 137th Canton Fair has successfully hosted a Southeast Asia roadshow...
